BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wenzel J, Grabinski N, Knopp CA, Dendorfer A, Ramanjaneya M, Randeva HS, Ehrhart-Bornstein M, Dominiak P, Jöhren O. Hypocretin/orexin increases the expression of steroidogenic enzymes in human adrenocortical NCI H295R cells. Am J Physiol Regul Integr Comp Physiol 2009;297:R1601-9. [PMID: 19793950 DOI: 10.1152/ajpregu.91034.2008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Louw-du Toit R, Perkins MS, Snoep JL, Storbeck KH, Africander D. Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids. PLoS One 2016;11:e0164170. [PMID: 27706226 DOI: 10.1371/journal.pone.0164170] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Chang X, Zhao Y, Guo L. Effect of Orexin-A on Cortisol Secretion in H295R Cells via p70S6K/4EBP1 Signaling Pathway. Int J Endocrinol 2015;2015:405157. [PMID: 26064108 DOI: 10.1155/2015/405157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
3 Couvineau A, Dayot S, Nicole P, Gratio V, Rebours V, Couvelard A, Voisin T. The Anti-tumoral Properties of Orexin/Hypocretin Hypothalamic Neuropeptides: An Unexpected Therapeutic Role. Front Endocrinol (Lausanne) 2018;9:573. [PMID: 30319552 DOI: 10.3389/fendo.2018.00573] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
4 Graybill NL, Weissig V. A review of orexin's unprecedented potential as a novel, highly-specific treatment for various localized and metastatic cancers. SAGE Open Med 2017;5:2050312117735774. [PMID: 29147564 DOI: 10.1177/2050312117735774] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
5 Kotz C, Nixon J, Butterick T, Perez-Leighton C, Teske J, Billington C. Brain orexin promotes obesity resistance. Ann N Y Acad Sci 2012;1264:72-86. [PMID: 22803681 DOI: 10.1111/j.1749-6632.2012.06585.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
6 Wang C, Wang Q, Ji B, Pan Y, Xu C, Cheng B, Bai B, Chen J. The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. Front Mol Neurosci 2018;11:220. [PMID: 30002617 DOI: 10.3389/fnmol.2018.00220] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 13.8] [Reference Citation Analysis]
7 Mangelis A, Dieterich P, Peitzsch M, Richter S, Jühlen R, Hübner A, Willenberg HS, Deussen A, Lenders JW, Eisenhofer G. Computational analysis of liquid chromatography-tandem mass spectrometric steroid profiling in NCI H295R cells following angiotensin II, forskolin and abiraterone treatment. The Journal of Steroid Biochemistry and Molecular Biology 2016;155:67-75. [DOI: 10.1016/j.jsbmb.2015.09.038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
8 Ramanjaneya M, Karteris E, Chen J, Rucinski M, Ziolkowska A, Ahmed N, Kagerer S, Jöhren O, Lehnert H, Malendowicz LK, Randeva HS. QRFP induces aldosterone production via PKC and T-type calcium channel-mediated pathways in human adrenocortical cells: evidence for a novel role of GPR103. Am J Physiol Endocrinol Metab 2013;305:E1049-58. [PMID: 23964068 DOI: 10.1152/ajpendo.00191.2013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
9 Basini G, Ciccimarra R, Bussolati S, Grolli S, Ragionieri L, Ravanetti F, Botti M, Gazza F, Cacchioli A, Di Lecce R, Cantoni A, Grasselli F. Orexin A in swine corpus luteum. Domestic Animal Endocrinology 2018;64:38-48. [DOI: 10.1016/j.domaniend.2018.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
10 Kukkonen JP, Leonard CS. Orexin/hypocretin receptor signalling cascades. Br J Pharmacol 2014;171:314-31. [PMID: 23902572 DOI: 10.1111/bph.12324] [Cited by in Crossref: 104] [Cited by in F6Publishing: 91] [Article Influence: 13.0] [Reference Citation Analysis]
11 Kukkonen JP. Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol 2013;304:C2-32. [PMID: 23034387 DOI: 10.1152/ajpcell.00227.2012] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 9.3] [Reference Citation Analysis]
12 Razavinia F, Tehranian N, Sadatmahalleh SJ, Kazemnejad A, Khajetash S, Daryasari SRF, Pahlavan F, Jahanfar S. The influence of mode of delivery, anthropometric indices, and infant's sex on the maternal and cord blood orexin-A levels: A cohort study. J Obstet Gynaecol Res 2021;47:2363-70. [PMID: 33870593 DOI: 10.1111/jog.14758] [Reference Citation Analysis]
13 Kiezun M, Smolinska N, Dobrzyn K, Szeszko K, Rytelewska E, Kaminski T. The effect of orexin A on CYP17A1 and CYP19A3 expression and on oestradiol, oestrone and testosterone secretion in the porcine uterus during early pregnancy and the oestrous cycle. Theriogenology 2017;90:129-40. [PMID: 28166959 DOI: 10.1016/j.theriogenology.2016.11.028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
14 Wang C, Pan Y, Zhang R, Bai B, Chen J, Randeva HS. Heterodimerization of mouse orexin type 2 receptor variants and the effects on signal transduction. Biochim Biophys Acta 2014;1843:652-63. [PMID: 24368186 DOI: 10.1016/j.bbamcr.2013.12.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
15 Alain C, Pascal N, Valérie G, Thierry V. Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target. Molecules 2021;26:4849. [PMID: 34443437 DOI: 10.3390/molecules26164849] [Reference Citation Analysis]
16 Mlyczyńska E, Kieżun M, Kurowska P, Dawid M, Pich K, Respekta N, Daudon M, Rytelewska E, Dobrzyń K, Kamińska B, Kamiński T, Smolińska N, Dupont J, Rak A. New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides. Cells 2022;11:957. [DOI: 10.3390/cells11060957] [Reference Citation Analysis]
17 Guo Y, Feng P. OX2R activation induces PKC-mediated ERK and CREB phosphorylation. Exp Cell Res 2012;318:2004-13. [PMID: 22652455 DOI: 10.1016/j.yexcr.2012.04.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
18 Kukkonen JP. Orexin/Hypocretin Signaling. Curr Top Behav Neurosci 2017;33:17-50. [PMID: 27909990 DOI: 10.1007/7854_2016_49] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
19 Greene ES, Zampiga M, Sirri F, Ohkubo T, Dridi S. Orexin system is expressed in avian liver and regulates hepatic lipogenesis via ERK1/2 activation. Sci Rep 2020;10:19191. [PMID: 33154530 DOI: 10.1038/s41598-020-76329-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Ventzke K, Oster H, Jöhren O. Diurnal Regulation of the Orexin/Hypocretin System in Mice. Neuroscience 2019;421:59-68. [DOI: 10.1016/j.neuroscience.2019.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
21 Rendic SP, Peter Guengerich F. Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits. Drug Metab Rev 2018;50:256-342. [PMID: 30717606 DOI: 10.1080/03602532.2018.1483401] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
22 Kagerer SM, Eichholz C, Jöhren O. Orexins/hypocretins increase the promoter activity of selective steroidogenic enzymes. Peptides 2011;32:839-43. [PMID: 21256172 DOI: 10.1016/j.peptides.2011.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
23 Ragionieri L, Ravanetti F, Di Lecce R, Botti M, Ciccimarra R, Bussolati S, Basini G, Gazza F, Cacchioli A. Immunolocalization of Orexin A and its receptors in the different structures of the porcine ovary. Ann Anat 2018;218:214-26. [PMID: 29738835 DOI: 10.1016/j.aanat.2018.04.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Lee Y, Dai YE, Huang S, Li T, Hwang L. Blockade of central orexin 2 receptors reduces arterial pressure in spontaneously hypertensive rats: Role of orexin in hypertension. Experimental Physiology 2013;98:1145-55. [DOI: 10.1113/expphysiol.2013.072298] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
25 Peltonen HM, Åkerman KE, Bart G. A role for PKD1 and PKD3 activation in modulation of calcium oscillations induced by orexin receptor 1 stimulation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2010;1803:1206-12. [DOI: 10.1016/j.bbamcr.2010.07.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
26 Leonard CS, Kukkonen JP. Orexin/hypocretin receptor signalling: a functional perspective. Br J Pharmacol 2014;171:294-313. [PMID: 23848055 DOI: 10.1111/bph.12296] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 10.3] [Reference Citation Analysis]
27 Kisielewska K, Rytelewska E, Gudelska M, Kiezun M, Dobrzyn K, Szeszko K, Bors K, Wyrebek J, Kaminski T, Smolinska N. The effect of orexin B on steroidogenic acute regulatory protein, P450 side-chain cleavage enzyme, and 3β-hydroxysteroid dehydrogenase gene expression, and progesterone and androstenedione secretion by the porcine uterus during early pregnancy and the estrous cycle. J Anim Sci 2019;97:851-64. [PMID: 30508170 DOI: 10.1093/jas/sky458] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]